Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Director · PRESIDENT, CEO AND DIRECTOR | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,499.2826 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 127.6843 · Balance 25,499.2826 F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date December 31, 2018 · Filed February 01, 2019
Section 16 reporting ended · disclosed 2019-02-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,258 |
Reported balance
After 2018-03-13 transaction · row 1
1 source rowRow 1 · 2018-03-13 · Gift · Disposed 3,200 · Balance 132,258 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,093 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,093 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 20:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 127.6843 | $22.14 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000045 · form4-10062026_081045.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,499.2826 Underlying: Common Stock · 127.6843 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 126.0897 | $22.42 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000043 · form4-09222026_080919.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,371.5983 Underlying: Common Stock · 126.0897 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 115.3849 | $24.50 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000041 · form4-09092026_090920.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,245.5086 Underlying: Common Stock · 115.3849 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 117.9362 | $23.97 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000039 · form4-08252026_080815.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,130.1237 Underlying: Common Stock · 117.9362 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 07, 2026 Filed Aug 10, 2026 20:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 127.7997 | $22.12 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000037 · form4-08102026_080838.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,012.1875 Underlying: Common Stock · 127.7997 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 24, 2026 Filed Jul 28, 2026 21:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 113.4857 | $24.91 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000035 · form4-07282026_090733.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,884.3878 Underlying: Common Stock · 113.4857 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 20:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 113.8973 | $24.82 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000033 · form4-07142026_080734.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,770.9021 Underlying: Common Stock · 113.8973 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 115.0562 | $24.57 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000031 · form4-06302026_080648.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,657.0048 Underlying: Common Stock · 115.0562 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 116.9603 | $24.17 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000029 · form4-06162026_080634.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,541.9486 Underlying: Common Stock · 116.9603 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 118.5296 | $23.85 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000027 · form4-06022026_090645.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,424.9883 Underlying: Common Stock · 118.5296 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 142.3429 | $19.86 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000025 · form4-05192026_080522.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,306.4587 Underlying: Common Stock · 142.3429 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 4,971 | $20.09 | $99,842.54 |
DisclosureSEC source: 0001479079-26-000025 · form4-05192026_080522.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Indirect · By Revocable Trust Disclosed balance after: 171,971 Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:12 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 125.5855 | $22.51 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000023 · form4-05052026_080521.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,164.1158 Underlying: Common Stock · 125.5855 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 119.3805 | $23.68 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000021 · form4-04212026_080442.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,038.5303 Underlying: Common Stock · 119.3805 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 21:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 123.8795 | $22.82 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000019 · form4-04072026_090444.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,919.1498 Underlying: Common Stock · 123.8795 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 117.887 | $23.98 | $2,826.93 |
DisclosureSEC source: 0001479079-26-000017 · form4-03242026_080346.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,795.2703 Underlying: Common Stock · 117.887 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 4,497.6194 | $23.36 | $105,064.39 |
DisclosureSEC source: 0001479079-26-000015 · form4-03102026_080323.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,677.3833 Underlying: Common Stock · 4,497.6194 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:17 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 37,898 | $24.88 | $942,902.24 |
DisclosureSEC source: 0001479079-26-000013 · form4-03052026_090330.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051,898 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units (Match) · Derivative | 6,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · derivative · entry 6 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,593 Underlying: Common Stock · 6,593 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F5 · derivative.exercise_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F5 · derivative.expiration_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 243,809 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · derivative · entry 5 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,809 Underlying: Common Stock · 243,809 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 119,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,089,796 F2 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 229,982 | $26.40 | $6,071,524.80 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,970,477 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 397,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200,459 F1 · balance_after: Includes 1,038 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:44 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 110.8583 | $24.98 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000009 · form4-02242026_090216.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,179.7639 Underlying: Common Stock · 110.8583 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:32 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 109.8905 | $25.20 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000007 · form4-02102026_090248.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,068.9056 Underlying: Common Stock · 109.8905 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 113.4934 | $24.40 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000005 · form4-01272026_090113.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,959.0151 Underlying: Common Stock · 113.4934 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 117.9906 | $23.47 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000003 · form4-01132026_110108.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,845.5217 Underlying: Common Stock · 117.9906 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 122.5327 | $22.60 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000021 · form4-12302025_091245.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,727.5311 Underlying: Common Stock · 122.5327 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 130.0723 | $21.29 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000019 · form4-12162025_091204.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,604.9984 Underlying: Common Stock · 130.0723 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 22,000 | $21.75 | $478,495.60 |
DisclosureSEC source: 0001479079-25-000017 · form4-12152025_091220.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Indirect · By Revocable Trust Disclosed balance after: 167,000 F1 · price: Reflects the weighted average price of 22,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.739 to $21.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 119.0047 | $23.27 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000015 · form4-12022025_101203.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,474.9261 Underlying: Common Stock · 119.0047 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:46 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 131.3058 | $21.09 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000013 · form4-11182025_091100.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,355.9214 Underlying: Common Stock · 131.3058 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 125.0221 | $22.15 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000011 · form4-11042025_091105.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,224.6156 Underlying: Common Stock · 125.0221 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 20:21 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 129.2829 | $21.42 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000008 · form4-10212025_081048.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,099.5935 Underlying: Common Stock · 129.2829 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:46 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 134.1686 | $20.64 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000006 · form4-10072025_081033.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,970.3106 Underlying: Common Stock · 134.1686 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 21:02 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 144.2313 | $19.20 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000004 · form4-09232025_090957.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,836.142 Underlying: Common Stock · 144.2313 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:42 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 150.2572 | $18.43 | $2,769.24 |
DisclosureSEC source: 0001415889-25-023979 · form4-09092025_080902.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,691.9107 Underlying: Common Stock · 150.2572 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 21:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 154.6198 | $17.91 | $2,769.24 |
DisclosureSEC source: 0001415889-25-023047 · form4-08262025_090805.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,541.6535 Underlying: Common Stock · 154.6198 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:55 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 166.1212 | $16.67 | $2,769.24 |
DisclosureSEC source: 0001415889-25-021511 · form4-08122025_090842.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,387.0337 Underlying: Common Stock · 166.1212 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 20:24 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 185.6059 | $14.92 | $2,769.24 |
DisclosureSEC source: 0001415889-25-020457 · form4-07292025_080751.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,220.9125 Underlying: Common Stock · 185.6059 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 185.855 | $14.90 | $2,769.24 |
DisclosureSEC source: 0001415889-25-019767 · form4-07152025_080733.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,035.3066 Underlying: Common Stock · 185.855 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 27, 2025 Filed Jun 30, 2025 22:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 193.7887 | $14.29 | $2,769.24 |
DisclosureSEC source: 0001415889-25-018553 · form4-06302025_100606.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,849.4516 Underlying: Common Stock · 193.7887 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:48 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 200.5243 | $13.81 | $2,769.24 |
DisclosureSEC source: 0001415889-25-017549 · form4-06172025_080623.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,655.6629 Underlying: Common Stock · 200.5243 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:33 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 206.0446 | $13.44 | $2,769.24 |
DisclosureSEC source: 0001415889-25-015435 · form4-06032025_090621.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,455.1386 Underlying: Common Stock · 206.0446 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 214.3375 | $12.92 | $2,769.24 |
DisclosureSEC source: 0001415889-25-013830 · form4-05202025_090510.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,249.094 Underlying: Common Stock · 214.3375 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 284.0246 | $9.75 | $2,769.24 |
DisclosureSEC source: 0001415889-25-012093 · form4-05062025_080525.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,034.7565 Underlying: Common Stock · 284.0246 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 21:21 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 326.5613 | $8.48 | $2,769.24 |
DisclosureSEC source: 0001415889-25-011157 · form4-04222025_090429.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,750.7319 Underlying: Common Stock · 326.5613 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 302.6492 | $9.15 | $2,769.24 |
DisclosureSEC source: 0001415889-25-010421 · form4-04082025_090447.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,424.1706 Underlying: Common Stock · 302.6492 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 23:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 262.9858 | $10.53 | $2,769.24 |
DisclosureSEC source: 0001415889-25-008964 · form4-03252025_110327.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,121.5214 Underlying: Common Stock · 262.9858 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8,902.8043 | $11.14 | $99,177.24 |
DisclosureSEC source: 0001415889-25-007679 · form4-03112025_090346.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,858.5356 Underlying: Common Stock · 8,902.8043 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.